About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. 

Leukemia. 2025

PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms. 

Leukemia and Lymphoma. 2025

Personalized medicine in histiocytic disorders: novel targets in patients without MAPK alterations. 

JCO precision oncology. 2024

Contact

full name

K. L. Rech

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science